These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 3109328
1. [Combined effect of human recombinant interferon-beta and interferon-gamma against an experimental model of peritonitis carcinomatosa in nude mice]. Kondo H, Tanaka N, Naomoto Y, Orita K. Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1836-40. PubMed ID: 3109328 [Abstract] [Full Text] [Related]
6. Effects of interleukin-2 and interferon-beta treatment on lymphocytes in various tumor-bearing mice. Iigo M, Nishikata K, Nakajima Y, Moriyama M. J Biol Regul Homeost Agents; 1989 Jun; 3(3):108-11. PubMed ID: 2516403 [Abstract] [Full Text] [Related]
7. [Assessment of the combined effects of mitomycin C with alpha-interferon or gamma-interferon by the clonogenic assay technique]. Hirabayshi N, Nishiyama M, Yamaguchi M, Yoshinaka K, Nosoh Y, Toge T, Niimoto M, Hattori T, Ohkita T. Gan To Kagaku Ryoho; 1985 May; 12(5):1056-62. PubMed ID: 3922307 [Abstract] [Full Text] [Related]
8. [Combined effect of human recombinant interferon alpha, beta and gamma on tumor cell growth and the cell cycle in vitro]. Kondo H, Tanaka N, Naomoto Y, Orita K. Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1234-9. PubMed ID: 3107476 [Abstract] [Full Text] [Related]
9. [Antitumor efficacy of recombinant interferon-beta on human glioma]. Miyao Y, Shimizu K, Okamoto Y, Matsui Y, Tsuda N, Yamada M, Tamura K, Mogami H. Gan To Kagaku Ryoho; 1987 Feb; 14(2):490-4. PubMed ID: 3813577 [Abstract] [Full Text] [Related]
13. Changes in lymphocyte subsets following multiple administration of recombinant interleukin-2 plus recombinant interferon-beta or -gamma in tumor-bearing mice. Iigo M, Nishikata K, Nakajima Y, Moriyama M. Jpn J Cancer Res; 1989 Jun; 80(6):554-61. PubMed ID: 2527216 [Abstract] [Full Text] [Related]
16. Effect of rIFN-gamma and IL-2 treatments in mouse and nude rat infections with Toxoplasma gondii. Benedetto N, Auriault C, Darcy F, Lando D, Watier H, Capron A. Eur Cytokine Netw; 1991 Jun; 2(2):107-14. PubMed ID: 1813013 [Abstract] [Full Text] [Related]
18. [Antitumor effects of recombinant human leukocyte interferon (rIFN-alpha A) on human malignomas transplanted into nude mice]. Hashizume S. Gan To Kagaku Ryoho; 1985 Feb; 12(2):284-8. PubMed ID: 3970552 [Abstract] [Full Text] [Related]
19. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD. Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [Abstract] [Full Text] [Related]
20. [In vitro enhancement of cytotoxicity of human peripheral blood lymphocytes with recombinant interleukin 2 and an interferon mixture (alpha + beta + gamma) against human colon carcinoma cell line SW1116]. Kimoto Y. Gan To Kagaku Ryoho; 1986 Dec; 13(12):3419-26. PubMed ID: 3098183 [Abstract] [Full Text] [Related] Page: [Next] [New Search]